JP2017525671A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525671A5
JP2017525671A5 JP2017500060A JP2017500060A JP2017525671A5 JP 2017525671 A5 JP2017525671 A5 JP 2017525671A5 JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017500060 A JP2017500060 A JP 2017500060A JP 2017525671 A5 JP2017525671 A5 JP 2017525671A5
Authority
JP
Japan
Prior art keywords
particles
micronized
diameter
walton
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017500060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017525671A (ja
JP6640826B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/039444 external-priority patent/WO2016007554A1/en
Publication of JP2017525671A publication Critical patent/JP2017525671A/ja
Publication of JP2017525671A5 publication Critical patent/JP2017525671A5/ja
Application granted granted Critical
Publication of JP6640826B2 publication Critical patent/JP6640826B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017500060A 2014-07-08 2015-07-07 微粒子化ワルトン膠質 Active JP6640826B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462022084P 2014-07-08 2014-07-08
US62/022,084 2014-07-08
PCT/US2015/039444 WO2016007554A1 (en) 2014-07-08 2015-07-07 Micronized wharton's jelly

Publications (3)

Publication Number Publication Date
JP2017525671A JP2017525671A (ja) 2017-09-07
JP2017525671A5 true JP2017525671A5 (enExample) 2018-08-16
JP6640826B2 JP6640826B2 (ja) 2020-02-05

Family

ID=55064792

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017500060A Active JP6640826B2 (ja) 2014-07-08 2015-07-07 微粒子化ワルトン膠質

Country Status (5)

Country Link
US (3) US20160008410A1 (enExample)
EP (1) EP3167049A4 (enExample)
JP (1) JP6640826B2 (enExample)
AU (1) AU2015287920A1 (enExample)
WO (1) WO2016007554A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2999420A1 (en) 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
EP2717888B1 (en) 2011-06-10 2020-09-09 Tissuetech, Inc. Methods of processing fetal support tissues
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
WO2016111899A1 (en) 2015-01-05 2016-07-14 Petrucci Gary M Methods and materials for treating lung disorders
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TWI720984B (zh) 2015-05-20 2021-03-11 美商帝聖工業公司 用於防止上皮細胞增生及上皮-間質轉移之組合物及方法
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
US10993969B2 (en) 2016-02-05 2021-05-04 Gary M. Petrucci Methods and materials for treating nerve injuries and neurological disorders
EP3439676B1 (en) 2016-04-04 2021-06-09 Omeza LLC Fish oil topical composition
US10478531B2 (en) * 2017-06-22 2019-11-19 Gary M. Petrucci Methods and materials for treating blood vessels
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
JP7684908B2 (ja) * 2019-04-16 2025-05-28 ライフネット ヘルス 出産組織由来の生成物並びにその調製及び使用
WO2022186946A1 (en) * 2021-03-03 2022-09-09 Axogen Corporation Human umbilical cord-derived compositions and uses thereof for treating neuropathy
US20220280573A1 (en) * 2021-03-03 2022-09-08 Axogen Corporation Human umbilical cord-derived compositions and uses thereof for treating neuropathy
EP4487878A1 (en) * 2022-03-01 2025-01-08 National Yang Ming Chiao Tung University Wharton's jelly product capable of promoting osteogenesis

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
US5558071A (en) 1994-03-07 1996-09-24 Combustion Electromagnetics, Inc. Ignition system power converter and controller
US5919702A (en) * 1996-10-23 1999-07-06 Advanced Tissue Science, Inc. Production of cartilage tissue using cells isolated from Wharton's jelly
IL134830A0 (en) 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
CN1487836A (zh) 2000-03-14 2004-04-07 埃米林药品公司 胰高糖素样肽1(7-36)对胃窦幽门十二指肠能动性的影响
WO2003032735A1 (en) * 2001-10-18 2003-04-24 Lifecell Corporation Remodeling of tissues and organs
WO2005079741A1 (en) 2004-02-13 2005-09-01 Cognis France S.A.S. Cosmetic composition comprising an extract of the leaves of castanea sativa
US9005646B2 (en) 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
WO2008021391A1 (en) 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8372437B2 (en) 2006-08-17 2013-02-12 Mimedx Group, Inc. Placental tissue grafts
JP5765884B2 (ja) 2006-09-25 2015-08-19 アーチャー−ダニエルズ−ミッドランド カンパニー 超吸収性表面処理カルボキシアルキル化多糖類及びその製造方法
WO2008060377A2 (en) 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
EP4559488A3 (en) 2007-09-07 2025-08-13 MiMedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same
CA2735899A1 (en) 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
CN102176881B (zh) * 2008-10-10 2014-12-10 海斯特赛尔有限公司 来自人脐带的脐带胶质的新生物材料
ES2768968T3 (es) 2009-08-25 2020-06-24 Tissue Tech Inc Productos de la membrana amniótica del cordón umbilical
CN102198292B (zh) 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
EP3311826B1 (en) 2011-02-14 2020-04-29 MiMedx Group, Inc. Micronized placental tissue compositions and methods for making and using the same
WO2012112410A2 (en) 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
KR20140114277A (ko) * 2011-02-14 2014-09-26 미메딕스 그룹 인크. 바르톤 젤리로 이루어진 라미네이트된 조직 이식편 및 그것의 제조 및 사용 방법
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
CN103703069B (zh) * 2011-07-27 2017-05-03 普立万公司 可交联的生物增塑剂
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
PT3321355T (pt) 2011-12-30 2021-09-28 Patel Amit Métodos e composições para a derivação clínica de uma célula alogénica e utilizações terapêuticas
US8904664B2 (en) 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
CA2880157C (en) 2012-08-15 2020-07-21 Mimedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US20140106447A1 (en) 2012-10-12 2014-04-17 Mimedx Group, Inc. Compositions and methods for recruiting stem cells
JP6756612B2 (ja) * 2013-08-30 2020-09-16 ミメディクス グループ インコーポレイテッド キレーターを含む微粒子化した胎盤性組成物
WO2015179711A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
US20160000968A1 (en) 2014-07-07 2016-01-07 Mimedx Group, Inc. Placental tissue grafts and improved methods of preparing and using the same

Similar Documents

Publication Publication Date Title
JP2017525671A5 (enExample)
Sharma et al. An insight into functionalized calcium based inorganic nanomaterials in biomedicine: Trends and transitions
Najafi-Hajivar et al. Overview on experimental models of interactions between nanoparticles and the immune system
JP2017517255A5 (enExample)
AU2015287920A8 (en) Micronized Wharton's Jelly
MX2021007794A (es) Composiciones y metodos para aplicaciones oftalmicas y/u otras aplicaciones.
JP2014240439A5 (enExample)
JP2016504362A5 (enExample)
MX355611B (es) Formulaciones de anticuerpos monoclonales de alta concentracion.
WO2015050814A3 (en) Therapeutic agents for delivery using a catheter and pressure source
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
JP2014000094A5 (ja) 臍帯由来細胞を用いた局部的または散在的脳外傷の改善
WO2014194254A8 (en) Treatment of cancers using pi3 kinase isoform modulators
PH12017500479A1 (en) Liquid inhalation formulation comprising prl554
JP2014526447A5 (enExample)
BR112013027674A2 (pt) "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
MX2014000141A (es) Agentes de enlace a receptor de canabinoide, composiciones y metodos.
IL294463A (en) Methods for treating or preventing eye conditions
JP2014509319A5 (enExample)
Gomzikova et al. Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells
WO2015152693A3 (ko) 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물
HRP20191366T4 (hr) Injekcijski pripravak
MX2015015589A (es) Composiciones y metodos para el suministro de agentes activos hidrófobos.
JP2013544781A5 (enExample)
WO2014106116A3 (en) Therapeutic compositions comprising antibodies